The Impact of Phosphate Metabolism on Healthy Aging
Conditions
Diseases of the Kidney & Urinary Tract
Phase Pilot
Volunteers
Health Professionals
What is the purpose of this trial?
Brief Summary:
Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial function), and cardiovascular function (echo- cardiography) in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and patients with X-linked hypophosphatemia (XLH).
- Ages13 years and older
- GenderBoth
- Trial withNational Center for Advancing Translational Sciences (NCATS)
- Start Date12/03/2019
- End Date11/30/2022
For more information about this study, contact:
Clemens Bergwitz
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Sub-Investigators
- Last Updated07/15/2021
- Study HIC#2000023461